DalsnaFinance Account

GE HealthCare $GEHC

Health Care · Health Care Equipment · NASDAQ

S&P 500 Nasdaq-100 Russell 1000 Illinois

Create a scorecard

$68.47

-0.32 (-0.47%)

As of Oct 15, 2026, 12:17 AM EDT

Price history

Loading chart…

Today's analyst average Analyst average over timeIndividual analyst targets Analyst history starts Oct 5, 2026, the first target we tracked for GEHC.

GE HealthCare (GEHC) is trading down at $68.47 (-0.47%) on NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.

Analyst price targets on GEHC

Current price targets from 2 firms average $86.5, ranging from $80 to $93 — 26% above the current $68.5. Each is tracked to its date and scored the same way a member's call is.

Needham $65.1 → $93 by Oct 2027 Buy Oct 5, 2026 via Investing.com · Needham's track record
RBC Capital Markets $65.1 → $80 by Oct 2027 Outperform Oct 5, 2026 via Investing.com · RBC Capital Markets's track record

Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.

GE HealthCare revenue & net income history (FY2021–FY2025)

RevenueNet incomeNet margin (right axis, %)

GE HealthCare annual financial statements
	FY2021Dec 2021	FY2022Dec 2022	FY2023Dec 2023	FY2024Dec 2024	FY2025Dec 2025
Income statement
Revenue	$17.6B	$18.3B	$19.6B	$19.7B	$20.6B
Growth (year over year)	—	+4.3%	+6.6%	+0.6%	+4.8%
Gross profit	$7.17B	$7.18B	$7.92B	$8.21B	$8.25B
Gross margin	40.8%	39.1%	40.5%	41.7%	40.0%
Operating income	$2.79B	$2.52B	$2.44B	$2.63B	$2.76B
Operating margin	15.9%	13.8%	12.5%	13.3%	13.4%
Net income	$2.25B	$1.92B	$1.57B	$1.99B	$2.08B
Net margin	12.8%	10.4%	8.0%	10.1%	10.1%
EPS (diluted)	$4.95	$4.22	$3.03	$4.34	$4.55
Balance sheet
Cash and equivalents	$561.0M	$1.44B	$2.49B	$2.87B	$4.49B
Total assets	—	$27.5B	$32.5B	$33.1B	$36.9B
Total liabilities	—	$17.9B	$25.1B	$24.4B	$26.3B
Long-term debt	—	$8.23B	$8.44B	$7.45B	$9.49B
Shareholders' equity	$16.7B	$9.36B	$7.13B	$8.45B	$10.4B
Cash flow
Operating cash flow	$1.61B	$2.13B	$2.10B	$1.96B	$1.99B
Capital expenditure	$248.0M	$310.0M	$387.0M	$401.0M	$482.0M
Free cash flow	$1.36B	$1.82B	$1.71B	$1.55B	$1.50B
Dividends paid	$0	$0	$41.0M	$55.0M	$64.0M
Share buybacks	—	—	$0	$0	$200.0M

RevenueNet incomeNet margin (right axis, %)

GE HealthCare quarterly financial statements
	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24^†Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25^†Dec 2025	Q1 FY26Mar 2026
Income statement
Revenue	$4.84B	$4.86B	$5.32B	$4.78B	$5.01B	$5.14B	$5.70B	$5.13B
Growth (year over year)	+0.5%	+0.9%	+2.2%	+2.7%	+3.5%	+5.8%	+7.1%	+7.4%
Gross profit	$2.00B	$2.03B	$2.27B	$2.01B	$1.99B	$1.99B	$2.26B	$1.98B
Gross margin	41.4%	41.7%	42.8%	42.1%	39.6%	38.7%	39.7%	38.5%
Operating income	$608.0M	$676.0M	$801.0M	$629.0M	$654.0M	$653.0M	$827.0M	$515.0M
Operating margin	12.6%	13.9%	15.1%	13.2%	13.1%	12.7%	14.5%	10.0%
Net income	$428.0M	$470.0M	$721.0M	$564.0M	$486.0M	$446.0M	$588.0M	$389.0M
Net margin	8.8%	9.7%	13.6%	11.8%	9.7%	8.7%	10.3%	7.6%
EPS (diluted)	$0.93	$1.02	$1.58	$1.23	$1.06	$0.98	$1.28	$0.85
Balance sheet
Cash and equivalents	$2.00B	$3.55B	$2.87B	$2.45B	$3.74B	$4.00B	$4.49B	$2.26B
Total assets	$31.9B	$33.9B	$33.1B	$33.6B	$35.5B	$36.1B	$36.9B	$37.1B
Total liabilities	$23.9B	$25.3B	$24.4B	$24.2B	$25.5B	$25.9B	$26.3B	$26.2B
Long-term debt	$8.23B	$9.31B	$7.45B	$6.76B	$8.27B	$8.28B	$9.49B	$10.1B
Shareholders' equity	$7.80B	$8.32B	$8.45B	$9.19B	$9.71B	$9.99B	$10.4B	$10.7B
Cash flow
Operating cash flow	−$119.0M	$742.0M	$913.0M	$250.0M	$94.0M	$593.0M	$1.05B	$290.0M
Capital expenditure	$64.0M	$90.0M	$102.0M	$152.0M	$86.0M	$110.0M	$134.0M	$178.0M
Free cash flow	−$183.0M	$652.0M	$811.0M	$98.0M	$8.00M	$483.0M	$916.0M	$112.0M
Dividends paid	$14.0M	$13.0M	$14.0M	$16.0M	$16.0M	$16.0M	$16.0M	$16.0M
Share buybacks	—	$0	$0	$0	$100.0M	$100.0M	$0	$100.0M

From GE HealthCare's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

About GE HealthCare

GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures contrast agents and radiopharmaceuticals.

Source: Wikipedia — GE HealthCare